KALA BIO, INC. Inventory
KALA BIO, INC. (KALA) had Inventory of $0 as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2023-03-03
- 2022-09-30: Inventory, Net $0.00.
- 2022-06-30: Inventory, Net $25.00K.
- 2022-03-31: Inventory, Net $10.53M.
- 2021-12-31: Inventory, Net $8.64M.
| Period end | Inventory, Net |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $25.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.53M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.64M 10-K · filed 2023-03-03 |
| 2021-09-30 | $7.71M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.05M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.24M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $5.23M 10-K · filed 2022-03-29 |
| 2020-09-30 | $7.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.71M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.27M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.65M 10-K · filed 2021-02-25 |
| 2019-09-30 | $8.56M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.22M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $5.42M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.09M 10-K · filed 2020-02-12 |
| 2018-09-30 | $976.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |